# Ernexa Therapeutics Inc.: Form 8-K, filed Oct 24, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2022-10-24
- Accepted by EDGAR: Oct 24, 2022, 16:31 ET
- Period: 2022-10-18
- Accession: 0001140361-22-038231
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122038231/brhc10043208_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122038231/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122038231/brhc10043208_8k.htm

Filed Oct 24, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-038231. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.